|
|
Partial
and complete regression of breast cancer in patients in relation to dosage of
coenzyme Q10
Lockwood
K, Moesgaard S, Folkers K
Pharma
Nord, Vejle, Denmark
Relationships
of nutrition and vitamins to the genesis and prevention of cancer are
increasingly evident.
In a clinical protocol, 32 patients having -"high-risk"- breast cancer
were treated with antioxidants, fatty acids, and 90 mg. of CoQ10.
Six of the 32
patients showed partial tumor regression.
In one of these 6 cases, the dosage of
CoQ10 was increased to 390 mg.
In one month, the tumor was no longer palpable
and in another month, mammography confirmed the absence of tumor.
Encouraged,
another case having a verified breast tumor, after non-radical surgery and with
verified residual tumor in the tumor bed was then treated with 300 mg. CoQ10.
After 3 months, the patient was in excellent clinical condition and there was no
residual tumor tissue.
The bioenergetic activity of CoQ10, expressed as
hematological or immunological activity, may be the dominant but not the sole
molecular mechanism causing the regression of breast cancer.
PMID:
7908519 [PubMed - indexed for MEDLINE]
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7908519&dopt=Abstract
|
